Next, we examined the effect of PLD inhibition with CAY10594 in imatinib-resistant GIST cell lines, GIST-R9 (KITΔ560–578,D820V) and GIST430 cells (KITΔ560–576,V654A). The gene discussed is GPLD1; the disease is gastrointestinal stromal tumor.